In this review, we summarize the clinical, histopathological, and molecular features of central nervous system (CNS) tumors with BCOR internal tandem duplication, intracranial mesenchymal tumor with FET/CREB fusion, CNS CIC-rearranged sarcomas and primary intracranial sarcoma DICER1-mutant, now included in the 2021 WHO classification of CNS tumors. Possible relationships between tumors occurring in the CNS and their systemic counterparts are discussed.
Pizzimenti, C., Gianno, F., Gessi, M., Expanding the spectrum of "mesenchymal" tumors of the central nervous system, <<PATHOLOGICA>>, 2022; 114 (6): 457-464. [doi:10.32074/1591-951X-826] [https://hdl.handle.net/10807/275075]
Expanding the spectrum of "mesenchymal" tumors of the central nervous system
Gessi, MarcoUltimo
Supervision
2022
Abstract
In this review, we summarize the clinical, histopathological, and molecular features of central nervous system (CNS) tumors with BCOR internal tandem duplication, intracranial mesenchymal tumor with FET/CREB fusion, CNS CIC-rearranged sarcomas and primary intracranial sarcoma DICER1-mutant, now included in the 2021 WHO classification of CNS tumors. Possible relationships between tumors occurring in the CNS and their systemic counterparts are discussed.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
